|
339 MHRA
negligent over Seroxat, says MIND chief MIND, the mental health
charity, has accused the Medicines and Healthcare products Regulatory
Agency of negligence. It argues that the agency failed to warn doctors
until last week not to prescribe, in the first instance, above the recommended
dose of paroxetine (Seroxat) ...more
339 Start
paroxetine at 20mg for depression Prescribers have been reminded
that the starting dose for paroxetine in adults should be 20mg daily
for most indications ...more
339 Budget
boosts NHS research Research in the NHS has been given a boost
by the Chancellor of the Exchequer, Gordon Brown, in his budget statement
delivered to the House of Commons on 17 March ...more
340 Another
pharmacist awarded Harkness Fellowship Rachel Elliott, clinical
senior lecturer at the University of Manchester school of pharmacy and
pharmaceutical sciences, has been awarded a Harkness Fellowship by the
US Commonwealth Fund ...more
340 Target
of 1,000 prescribers unlikely to be met There is “still some way to go” before the profession meets the government target of 1,000 pharmacists who are supplementary prescribers by the end of the year, according to Peter Wilson, consultant to the Royal Pharmaceutical Society and its lead on supplementary prescribing
...more
340 Benefits
from acupuncture when treating chronic headache Acupuncture
can provide persisting, clinically relevant benefits for primary care
patients with chronic headache, particularly migraine ...more
340 ESRC
recognition for Nottingham The centre for pharmacy, health
and society, at the University of Nottingham, has gained accreditation
by the Economic and Social Research Council for its postgraduate training
programme ...more
340 Oestrogen-alone
trial stopped Investigators for the US Women's Health Initiative
have revealed that taking HRT based on oestrogen alone over the long
term does not appear to affect heart disease or increase risk of breast
cancer but does increase risk of stroke ...more
340 HPV
linked with psoriasis therapy Psoriasis patients treated with
psoralens and ultraviolet light therapy have an increased prevalence
of human papilloma virus in their skin, say researchers ...more
341 Europe
to offer child medicine research incentives Pharmaceutical
manufacturers are to be given incentives to carry out child-safety studies
on medicines for use in Europe. Special paediatric licences will also
be available for generic medicines to give generics manufacturers an
incentive to do the work ...more
341 Medicines
among worst aspects of hospital experiences for children “Needles”, “awful-tasting medicine” and “being in pain” are among the worst aspects of being a child in hospital, according to some responses in a report published last week
...more
341 Industry
sponsorship of trials has increased dramatically Industry
sponsorship of clinical trials has increased dramatically over the past
20 years, according to Canadian pharmacists ...more
|
342 UK hypertension
guidelines updated Blood pressure guidelines, updated by the
British Hypertension Society (BHS), now include a treatment algorithm
to aid more logical use of antihypertensive drugs, alone and in combination
...more
342 New protease
inhibitor for HIV infection launched Adults infected with
HIV-1 who have already received antiretroviral treatment may benefit
from a new protease inhibitor launched on 10 March ...more
342 Gene variation
explains abacavir hypersensitivity Researchers have identified
a genetic variation associated with hypersensitivity to abacavir (Ziagen)
...more
343 Health Secretary
announces case management sites Health Secretary John Reid
announced a new programme for chronic disease management at a Birmingham
conference last week ...more
343 Pharmacists
should do more in care homes Greater involvement of pharmacists
in the management of medicines in registered care homes has been called
for by the National Care Standards Commission ...more
343 New public
protection measures for Scotland New rules governing the inclusion
of all health professionals on health board lists of primary care practitioners
have been proposed for Scotland. The effect will be to widen the checks
currently carried out on community pharmacists, GPs, dentists, optometrists
and ophthalmic medical practitioners ...more
344 GSK reprimanded
over medicines-review nurse GlaxoSmithKline has been reprimanded
over the actions of an asthma-audit nurse, sponsored by the company,
who made unauthorised changes to a GP repeat prescription database ...more
344 Parallel
imports can be repackaged Parallel importers can repackage
branded medicines if they need to do so to gain market acceptability
for these products ...more
344 Genzyme OFT
fine halved Genzyme has won a partial victory over the Office
of Fair Trading after appealing to the Competition Appeal Tribunal (CAT)
against a £6.8m fine imposed for breaking UK competition law ...more
344 Lipitor is
top seller worldwide Lipitor (atorvastatin) was the biggest
selling medicine worldwide in 2003, with global sales of US$10.3bn (up
14 per cent from 2002) ...more
344 Name change
leaflets Leaflets to help patients understand changes to the
names of many medicines have been produced by the National Pharmaceutical
Association ...more
344 Numark PI
service Numark has launched a one-stop parallel import service
for its pharmacy customers together with Phoenix Healthcare Distribution
Ltd ...more
|
The
Pharmaceutical Journal